Oncology CRO Email us info@sms-oncology.com
Follow us on

The 4D oncology CRO

Oncology trials ask for oncology experts

At SMS-oncology we believe that oncology trials ask for oncology experts. Being a full-service CRO dedicated to oncology, we provide the full range of clinical operations as well as expert advice along the oncology drug development path, tailored to the specific needs of our sponsors. Working at the forefront of innovative therapies we are specialized in the execution of early phase oncology and immuno-oncology trials.

Our unique competence and value proposition is our “4D” service in which we provide direction to our sponsors along the path of drug to data to dossier. We use our oncology drug development expertise to provide insightful strategic support and turn complex data into meaningful insights before and during study conduct. This proactive guidance helps our sponsors to be on top of the data, safeguard quality, enable informed decision making, mitigate risks and identify opportunities.

SMS-oncology, the 4D oncology CRO adding value by providing direction. 

Our oncology services

Clinical operations Read more

Clinical operations

From initiation and implementation to completion of oncology clinical trials with a specialization in:
• Early phase oncology trials
• Immuno-oncology trials

Consultancy Read more


From strategic expert advice on oncology drug development and trial design to protocol writing and scientific advisory boards.

4D service Read more

4D service

From upfront strategic advice translated into clinical operations to frequent meaningful insights during study conduct.

Our advantages

Responsiveness, Quality & Flexibility
  • Responsive and "right-sized" project teams for close collaboration, flexibility and fast-decision making
  • Close and personal involvement of the management team ensuring a high standard of quality
  • Delivering tailor made solutions by offering full or functional services as needed
Oncology Experts
  • In-depth knowledge of the complex nature of early phase oncology and immuno-oncology studies
  • Dedicated professionals with oncology know-how and experience in all functions of the company
  • Extensive network of Key Opinion Leaders throughout Europe
  • Proactively addressing challenges before they turn into hurdles
  • Strategic clinical development advice that can be directly translated into clinical operations
  • Turning complex data into meaningful insights during study conduct using our oncology expertise


3 June 2016

Our latetst newsletter Oncology Highlights - May 2016 is online!

26 May 2016

Our Business Developer Lindy Bosch is attending the Knowledge for Growth conference in Ghent, Belgium today!

24 May 2016

Two very interesting blogs CIMT 2016 "Mechanisms of efficacy in cancer immunotherapy" by Jasmijn Hubers (Medical Monitor) and CIMT 2016 - Rise of mRNA therapeutics, a relatively new class of treatment by Julia Holland (Consultant) are now online!

Conference schedule

14-15 September 2016

Nordic Life Science (NLS) Days, Stockholm, Sweden

28-30 September 2016

Biospain, Bilbao, Spain

3-5 October 2016

FIGON Dutch Medicines Days, Ede, the Netherlands

Recent blog posts